Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (5y) (2014 - 2026)
Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,469.00 |
| Dec 31, 2025 | -5,046.00 |
| Sep 30, 2025 | -7,939.00 |
| Jun 30, 2025 | 738,891.00 |
| Mar 31, 2025 | -6,575.00 |
| Dec 31, 2024 | -62,814.00 |
| Sep 30, 2024 | -12,118.00 |
| Jun 30, 2024 | 28,444.00 |
| Mar 31, 2024 | -20,614.00 |
| Dec 31, 2023 | -6,350.00 |
| Sep 30, 2023 | 8,637.00 |
| Jun 30, 2023 | -517.00 |
| Mar 31, 2023 | -7,645.00 |
| Dec 31, 2022 | -12,318.00 |
| Sep 30, 2022 | -4,659.00 |
| Jun 30, 2022 | -6,966.00 |
| Mar 31, 2022 | -5,735.00 |
| Dec 31, 2021 | 2,447.00 |
| Sep 30, 2021 | -7,902.00 |
| Jun 30, 2021 | 6,916.00 |